Showing results (541-550 of 889) with videos related to
Sort By:
Pageof 89
Drugs in R&D|August 8, 2013
Serum concentration of lignocaine after pertubation: an observational studyKarin Wickström, Jack Spira, Greta EdelstamDrugs in R&D|March 18, 2011
Cardiovascular safety profile of dapoxetine during the premarketing evaluationPeter R Kowey, Ramagopal V Mudumbi, Joseph W Aquilina, et al.Drugs in R&D|March 18, 2011
Comparison of the pharmacokinetic and pharmacodynamic profiles of one US-marketed and two European-marketed epoetin alfas: a randomized prospective studyMichael Lissy, Marité Ode, Karsten RothDrugs in R&D|September 10, 2011
Short-term acetylsalicylic acid (aspirin) use for pain, fever, or colds - gastrointestinal adverse effects: a meta-analysis of randomized clinical trialsAngel Lanas, Denis McCarthy, Michael Voelker, et al.Drugs in R&D|February 15, 2012
Combination of alpha lipoic acid and superoxide dismutase leads to physiological and symptomatic improvements in diabetic neuropathyFulvio Bertolotto, Antonino MassoneDrugs in R&D|November 27, 2014
Stability and recovery of DIFICID(®) (Fidaxomicin) 200-mg crushed tablet preparations from three delivery vehicles, and administration of an aqueous dispersion via nasogastric tubeAnna Tousseeva, J Derek Jackson, Mark Redell, et al.Drugs in R&D|November 15, 2014
Ibuprofen sodium is absorbed faster than standard Ibuprofen tablets: results of two open-label, randomized, crossover pharmacokinetic studiesThomas J Legg, Aziz L Laurent, Rina Leyva, et al.Drugs in R&D|October 17, 2014
No interacting influence of lavender oil preparation silexan on oral contraception using an ethinyl estradiol/levonorgestrel combinationDoris Heger-Mahn, Günther Pabst, Angelika Dienel, et al.Drugs in R&D|March 23, 2000
Current and novel agents for the treatment of cytomegalovirus retinitisT Akerele, S LightmanDrugs in R&D|April 14, 2000
Advances in the pharmacotherapy of migraine. How knowledge of pathophysiology is guiding drug developmentP J GoadsbyPageof 89